Mid-follicular LH supplementation in women aged 35-39 years undergoing ICSI cycles: A randomized controlled study

Reproductive BioMedicine Online

Volumn 19, Issue 6, 2009, Pages 879-887

  Matorras, R ^a,b   Prieto, B ^a   Exposito, A ^a   Mendoza, R ^a   Crisol, L ^a   Herranz, P ^c   Burgues S ^c  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b IVI Bilbao   (Spain)

^c MERCK KGAA   (Germany)

Author keywords

ICSI; Implantation; Metaphase II; Pregnancy; R HFSH; R HLH

Indexed keywords

FOLLITROPIN; LUTEINIZING HORMONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOLLICULAR PHASE; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; METHODOLOGY; NIDATION; OOCYTE RETRIEVAL; OVARY FOLLICLE; OVULATION INDUCTION; PHYSIOLOGY; PREGNANCY; PREGNANCY OUTCOME; RANDOMIZED CONTROLLED TRIAL;

ADULT; EMBRYO IMPLANTATION; FEMALE; FOLLICLE STIMULATING HORMONE, HUMAN; FOLLICULAR PHASE; HUMANS; LUTEINIZING HORMONE; OOCYTE RETRIEVAL; OVARIAN FOLLICLE; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; SPERM INJECTIONS, INTRACYTOPLASMIC;

EID: 77449095923     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2009.09.016     Document Type: Article

References (29)

1. Alviggi C, Clarizia R, Mollo A et al. 2006 Who needs LH in ovarian stimulation? Reproductive BioMedicine Online 12, 599-607.
2. Barrenetxea G, Agirregoikoa JA, Jiménez MR et al. 2008 Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in-vitro fertilization cycles. Fertility and Sterility 89, 546-553.
3. Blitek A, Ziecik AJ 2005 Effect of LH on prostaglandin F2alpha and prostaglandin E2 secretion by cultured porcine endometrial cells. Reproduction 130, 105-112.
4. Bosch E, Labarta E, Simón C et al. 2008 The impact of luteinizing hormone supplementation in gonadotropin releasing hormone antagonist cycles. An age adjusted randomized trial. Fertility and Sterility 90(suppl. 1), S41.
5. Cédrin-Durnerin I, Grange-Dujardin D, Laffy A et al. 2004 Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI cycles: a prospective randomized study. Human Reproduction 19, 1979-1984.
6. Couzinet B, Lestrat N, Brailly S 1988 Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotropin deficiency. Journal of Clinical Endocrinology and Metabolism 66, 552-556.
7. De Placido G, Mollo A, Clarizia R et al. 2006 Gonadotropin-releasing hormone (GnRH) antagonist plus recombinant luteinizing hormone vs a standard GnRH agonist short protocol in patients at risk for poor ovarian response. Fertility and Sterility 85, 247-250.
8. Durnerin CI, Erb K, Fleming R et al. 2008 Effects of recombinant LH treatment on folliculogenesis and responsiveness to FSH stimulation. Human Reproduction 23, 421-426.
9. Esposito MA, Barnhart KT, Coutifaris C, Patrizio P 2001 Role of periovulatory luteinizing hormone concentrations during assisted reproductive technology cycles stimulated exclusively with recombinant follicle-stimulating hormone. Fertility and Sterility 75, 519-524.
10. European Recombinant Human LH Study Group 1998 Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose finding study. Journal of Clinical Endocrinology and Metabolism 83, 1507-1514.
11. Fábregues F, Creus M, Peñarrubia J et al. 2006 Effects of recombinant human luteinizing hormone supplementation on ovarian stimulation and the implantation rate in down-regulated women of advanced reproductive age. Fertility and Sterility 85, 925-931.
12. Griesinger G, Schultze-Mosgau A, Dafopoulos K et al. 2005 Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol. Human Reproduction 20, 1200-1206.
13. Humaidan P, Bungum M, Bungum L, Yding Andersen C 2004 Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study. Reproductive BioMedicine Online 8, 635-643.
14. Humaidan P, Bungum M, Bungum L, Andersen C 2002 Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation. Human Reproduction 17, 2016-2021.
15. Kolibianakis EM, Kalogeropoulou L, Griesinger G et al. 2007 Among patients treated with FSH and GnRH analogues for in-vitro fertilization, is the addition of recombinant LH associated with the probability of live birth? A systematic review and meta-analysis. Human Reproduction Update 13, 445-452.
16. Lisi F, Rinaldi L, Fishel S et al. 2002 Use of recombinant LH in a group of unselected IVF patients. Reproductive BioMedicine Online 5, 104-108.
17. Marrs R, Meldrum D, Muasher S et al. 2004 Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment. Reproductive BioMedicine Online 8, 175-182.
18. Matorras R, Mendoza R, Expósito A, Rodríguez-Escudero FJ 2004 Influence of the time interval between embryo catheter loading and discharging on the success of IVF. Human Reproduction 19, 2027-2030.
19. Matorras R, Urquijo E, Mendoza R et al. 2002 Ultrasound-guided embryo transfer improves pregnancy rates and increases the frequency of easy transfers. Human Reproduction 17, 1762-1766.
20. Mishra S, Lei ZM, Rao ChV 2003 A novel role of luteinizing hormone in the embryo development in cocultures. Biological Reproduction 68, 1455-1462.
21. Mochtar MH, Vander Veen, Ziech M, vanWely M 2007 Recombinant luteinizing hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles. Cochrane Database of Systematic Reviews 2007, CD005070.
22. Nyboeandersen A, Humaidan P, Fried G et al. 2008 Recombinant LH supplementation to recombinant FSH during the final days of controlled ovarian stimulation for in-vitro fertilization. A multicentre, prospective, randomized, controlled trial. Human Reproduction 23, 427-434.
23. Reshef E, Lei ZM, Rao CV et al. 1990 The presence of gonadotropin receptors in nonpregnant human uterus, human placenta, fetal membranes, and decidua. Journal of Clinical Endocrinology and Metabolism 70, 421-430.
24. Shemesh M 2001 Actions of gonadotrophins on the uterus. Reproduction 121, 835-842.
25. Tarlatzis B, Tavmergen E, Szamatowicz M et al. 2006 The use of recombinant human LH (lutropin alfa) in the late stimulation phase of assisted reproduction cycles: a double-blind, randomized, prospective study. Human Reproduction 21, 90-94.
26. Tesarik J, Mendoza C 2002 Effects of exogenous LH administration during ovarian stimulation of pituitary down-regulated young oocyte donors on oocyte yield and developmental competence. Human Reproduction 17, 3129-3137.
27. Veeck LL 1988 Oocyte assessment and biological performance. Annals of the New York Academy of Science 541, 259-274.
28. Weghofer A, Munné S, Brannath W et al. 2008 The impact of LH-containing gonadotropins on diploidy rates in preimplantation embryos: long protocol stimulation. Human Reproduction 23, 499-503.
29. Westergaard LG, Laursen SB, Andersen CY 2000 Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction. Human Reproduction 15, 1003-1008.